# Liothyronine Sodium

NDC: 87063-080
Generic name: Liothyronine Sodium
Labeler / Manufacturer: ASCLEMED USA INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20121203

FDA application: ANDA200295

## Active ingredients

- LIOTHYRONINE SODIUM: 5 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"87063-080"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=87063-080
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26cf6872-f4d4-41dd-8957-a000f13efbb3